Register for OBR daily


COA_AnnualConf_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

BLRX $2.59 0.3500 +15.63%
ADXS $10.12 0.8000 +8.58%
ONCY $1.16 0.0900 +8.41%
OGXI $2.60 0.1900 +7.88%
CNDO $2.79 0.1900 +7.31%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

CERU $7.58 -0.6600 -8.01%
MNKD $6.16 -0.4800 -7.23%
APRI $2.39 -0.1400 -5.53%
FGEN $30.35 -1.7400 -5.42%
FPRX $24.76 -1.3300 -5.10%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

AstraZeneca to Carve Out Antibiotic R&D Into Separate Firm

(Reuters) Feb 27, 2015 - Drugmaker AstraZeneca has decided to carve out its early-stage antibiotic research by creating a stand-alone subsidiary company, as it sharpens its focus on other therapy areas.
read article 



Sanofi Diabetes Drug Toujeo Wins EU Green Light, Pricing in Focus

(Reuters) Feb 27, 2015 - French drugmaker Sanofi's new Toujeo diabetes drug has been recommended for approval in Europe, two days after being cleared for sale in the United States, regulators said on Friday.
read article 



Panel: Use New Meningitis Vaccines Only For Outbreaks

(ABC News/Associated Press) Feb 26, 2015 - A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.
read article 



Hospitals Mount Campaign Against Site-Neutral Medicare Payments

(ModernHealthcare) Feb 26, 2015 - Hospital leaders are working to head off any momentum in Congress toward overhauling Medicare rates to pay hospitals the same for outpatient services as the program pays for the same services in physician offices.
read article 



What You Should Know Before Watching Vice's Special About Curing Cancer

(Forbes) Feb 26, 2015 - Tomorrow night at 10 pm on the east and west coasts of the United States, Vice, the TV arm of the fast-growing Vice media empire, will air a special on HBO that posits that scientists are closing in on a cure for cancer.
read article 



Bringing the Oncology Care Model Into Focus

(ACCCBuzz) Feb 26, 2015 - As ACCC members are well aware, on February 12, the CMS Innovation Center (CMMI) released its much-anticipated Oncology Care Model (OCM) as part of the broader effort to lower healthcare costs and tie reimbursement to quality and value.
read article 



What Does the Future Hold For the Cancer Drugs Fund?

(The Guardian [UK]) Feb 27, 2015 - When the government created the Cancer Drugs Fund (CDF) in 2010 to pay for cancer drugs rejected by the National Institute for Care and Health Excellence (Nice), it was intended as a short-term stopgap until a longer-term solution to the problem of evaluating and funding cancer drugs for terminally ill patients could be developed.
read article 



Sky's the Limit For US Cancer Drug Prices, Says Top Doc

(Medscape Medical News) Feb 26, 2015 - There is no price that is too high for cancer drugs in the United States because Americans just can't say no, says Leonard Saltz, MD, from Memorial Sloan Kettering Cancer Center in New York City, in an editorial published online February 17 in the Journal of Clinical Oncology.
read article (free registration required) 



Too Many Scans For Aggressive Lymphoma in Clinical Trials

(Medscape Medical News) Feb 26, 2015 - Clinical trials do not mirror what is done in clinical practice when it comes to the number of scans required for patients with aggressive lymphoma.
read article (free registration required) 



New Survey Helps Doctors Better Assess Outcomes For Rectal Cancer Surgery

(MSKCC/OnCancer blog) Feb 26, 2015 - Surgery is the most common treatment for people with rectal cancer, but an operation is just the first step when it comes to restoring quality of life.
read article 



Merck’s 9-Valent HPV Vaccine, GARDASIL®9, Recommended by CDC’s Advisory Committee on Immunization Practices For Females Aged 9-26 and Males Aged 9-21

(MarketWatch) Feb 26, 2015 - Merck, known as MSD outside the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) voted to include GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in the recommendations for use of HPV vaccines.
read article 



CHMP Post-Authorisation Summary of Positive Opinion For Ristempa

(EMA) Feb 26, 2015 - On 26 February 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ristempa, 6mg, solution for injection intended for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy.
read article 



CHMP Post-Authorisation Summary of Positive Opinion For Avastin

(EMA) Feb 26, 2015 - On 26 February 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Avastin.
read article 



CHMP Post-Authorisation Summary of Positive Opinion For Vectibix

(EMA) Feb 26, 2015 - On 26 February 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending a variation to the terms of the marketing authorisation for the medicinal product Vectibix.
read article 



Terminal Cancer Care Should Do More to Treat Depression

(Reuters) Feb 26, 2015 - Depression could be clouding the last 24 hours of life for a significant number of people with advanced cancer, pointing to a need for better – and earlier - psychological help, according to a large study from Norway.
read article 



New Breast Cancer Test Links Immune ‘Hotspots’ to Better Survival

(Institute of Cancer Research [UK]) Feb 27, 2015 - Scientists have developed a new test which can predict the survival chances of women with breast cancer by analysing images of ‘hotspots’ where there has been a fierce immune reaction to a tumour.
read press release 



Anderson Algorithm Increases Surgical Success With Advanced Ovarian Cancer

(MD Anderson) Feb 27, 2015 - A surgical algorithm developed and implemented by ovarian cancer specialists at The University of Texas MD Anderson Cancer Center dramatically increases the frequency of complete removal of all visible tumor – a milestone strongly tied to improved survival.
read press release 



New Test Can Determine Effectiveness of Cancer Treatment Within 16 Hours

(FoxNews.com) Feb 26, 2015 - Researchers at Dana Farber Cancer Institute in Boston have developed a new technique that can predict which specific drug will be most effective in treating various types of cancer tumors.
read article 



Researchers Examine Etiology of Ibrutinib Discontinuation in CLL

(Doctors Lounge/HealthDay News) Feb 26, 2015 - For patients with chronic lymphocytic leukemia, the Bruton tyrosine kinase inhibitor ibrutinib is effective, and prognosis is poor after discontinuation, according to a study published online Feb. 26 in JAMA Oncology.
read article 



Zykadia Recommended For Approval in Advanced Non Small Cell Lung Cancer

(EMA) Feb 27, 2015 - The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for Zykadia (ceritinib).
read press release 



Biggest U.S. Health Insurer Tightens Rules on Hysterectomy Coverage

(Wall Street Journal) Feb 26, 2015 - UnitedHealth to require doctors to get authorization before performing most types of procedures; decision marks another blow to laparoscopic power morcellator, which can spread hidden cancer.
read article (paid subscription required) 



UnitedHealth Places Tighter Controls on Hysterectomies

(Reuters) Feb 26, 2015 - UnitedHealth Group Inc, the largest health insurer in the United States, is placing tighter controls on its coverage of hysterectomies after a device called a morcellator was linked to the spread of undiagnosed cancer cells.
read article 



Novartis Lung Cancer Drug Zykadia® Recommended for EU Approval in Patients with ALK+ NSCLC Previously Treated with Crizotinib

(Novartis) Feb 27, 2015 - Novartis announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a positive opinion for Zykadia® (ceritinib) to treat adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib.
read corporate press release 



EMA Will Review Amgen/Onyx' Myeloma Drug

(PharmaTimes [UK]) Feb 26, 2015 - The European Medicines Agency has accepted Amgen/Onyx’ Marketing Authorisation Application for Kyprolis (carfilzomib) as a treatment for multiple myeloma.
read article 



BIO Strongly Supports FDA Safety Over Sequestration Act; Urges Swift Consideration and Passage

(BIO) Feb 25, 2015 - The Biotechnology Industry Organization (BIO) today applauds Representatives Leonard Lance (R-NJ) and Anna Eshoo (D-CA) for introducing the FDA Safety Over Sequestration Act, or FDA SOS Act.
read press release